in this issue
EnviroTech :: Regulatory
Monsanto Seeks $100 Million in Damages from Novartis
2:05 PM MDT | August 20, 2007 | Chemical Week Editorial Staff
Monsanto says it has filed an arbitration claim against Novartis subsidiary Sandoz (Vienna) with the International Chamber of Commerce (Paris) over “quality assurance failures” at Sandoz’s Kundl, Austria pharmaceutical facility. Monsanto sources Posilac, an animal pharmaceutical supplement, from this facility. Monsanto says it is seeking $100 million in damages to compensate for “significant financial injury” resulting from supply disruptions to Monsanto customers that occurred while Sandoz was bringing its plant up to U.S. FDA...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee